Laboratory Measurements and Thorax Computed Tomography Findings for Inpatient Pregnant with COVID-19

INTRODUCTION: The purpose of this study was to evaluate the laboratory measurements and thorax computed tomography (CT) findings of pregnant women with COVID-19.
METHODS: This was a single-center, observational study performed in a Training and Research Hospital from March 1 to May 31, 2020. Laboratory data, clinical conditions, and thorax CT images of pregnant women with COVID-19 were analyzed retrospectively. The patients who agreed to the image and were not suspected of pneumonia were classified according to their degree of lung involvement.
RESULTS: A total of 155 pregnant women have included in the study, and the thorax CT of 86 (55.5%) pregnant women who participated in the study was evaluated. While no symptoms were observed in 44 (28.4%) of the pregnant women, the most common symptoms were dyspnea and cough in 27 (17.4%). Of the pregnant wom-en evaluated for thorax CT, 24 (27.9%) had negative, 19 (21.1%) had mild involvement, 30 (34.9%) had moderate involvement, and 13 (15.1%) had heavy involvement. C-reactive protein (CRP) levels of pregnant women with negative tomography were 4.5 (0.7–83.4) mg/L, 13.4 (0.7–107.3) mg/L with mild involvement, 37.7 (3.8–292.6) mg/L with moderate involvement and, 48.6 (5.7–234.1) mg/L with heavy involvement (p<0.001).
DISCUSSION AND CONCLUSION: All factors affecting the prognosis for pregnant women with COVID-19 have not been fully elucidated. It was determined that a significant frequency of pregnant women was asymptomatic. In addition, an increase was observed in the CRP level according to the severity of pneumonia, while no similar difference was found in the D-dimer level.